在卵泡液中的可溶性黄质化激素受体和在IVF和ICSI期间与生殖功能的关联

Li Juel Mortensen1, Mette Lorenzen2, Christine Hjorth Andreassen2

  • 1Group of Skeletal, Mineral, and Gonadal Endocrinology, Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Growth and Reproduction, and International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Denmark.

Reproductive biology
|December 6, 2024
PubMed
概括

血清和卵泡液中的可溶性黄化激素/胆激素受体 (sLHCGR) 水平在辅助生殖技术 (ART) 周期中没有预测怀孕或活产率. 需要进一步的研究来澄清sLHCGR在卵巢功能中的作用.